Di(2-ethylhexyl)phthalate exposure of apheresis donors is procedure-related [7]

Transfusion

Volumn 46, Issue 8, 2006, Pages 1459-1460

  Buchta, Christoph ^a   Dettke, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

APHERESIS; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; DEVICE; EXPOSURE; HUMAN; LEACHING; LETTER; THROMBOCYTOPHERESIS;

EID: 33746351007     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00921.x     Document Type: Letter

References (6)

1. Weisbach V, Koch HM, Angerer J, Eckstein V. Di(2-ethylhexyl)phthalate exposure of apheresis donors is procedure-related. Transfusion 2006;46:1457-8.
2. Buchta C, Bittner C, Höcker P, et al. Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis. Transfusion 2003;43:1115-20.
3. Buchta C, Bittner C, Heinzl H, et al. Transfusion-related exposure to the plasticizer di(2-ethylhexyl)phthalate in patients receiving plateletpheresis concentrates. Transfusion 2005;45:798-802.
4. Doull J, Cattley R, Elcombe C, et al. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new US EPA risk assessment guidelines. Regul Toxicol Pharmcol 1999;29:327-57.
5. Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices. Rockville (MD): Center for Devices and Radiological Health, U.S. Food and Drug Administration; 2001 [cited 2006 Feb]. Available from: http://www.fda.gov/cdrh/ost/dehp-pvc.pdf
6. 2-day repeat dose male reproductive tract study of di(2-ethylhexyl) phthalate (DEHP) administered either intravenously or orally to rats starting at neonatal age 3-5 days, with satellite recovery group through 90 days of age. Study number 11947. Washington (DC): AdvaMed; 2001.